You are here

obe-cel

5 Cell and Gene Therapy Decisions to Watch in 2024

BioSpace

Mon, 04/22/24 - 11:38 am

Abeona Therapeutics

recessive dystrophic epidermolysis bullosa

Rocket Pharmaceuticals

Leukocyte adhesion deficiency-1

advanced synovial sarcoma

Autolus Therapeutics

B cell acute lymphoblastic leukemia

Autolus announces primary endpoint met in FELIX trial, prices public offering

Pharmaphorum

Fri, 12/9/22 - 10:45 am

clinical trials

Blackstone continues biotech push with up to $250M cell therapy investment

BioPharma Dive

Mon, 11/8/21 - 10:56 am

Autolus Therapeutics